DAWES KAREN A

RGEN

DAWES KAREN A serves as Director at Repligen Corporation (RGEN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$28.9K

Total Sells

1 trades

$44.3K

Net Position

Net Seller

$15.4K

Companies Traded

RGEN, BRNS

Active Period

May 2021 – Dec 2025

2 total trades

Most Recent

Sell RGEN

Dec 17, 2025 · $44.3K

DAWES KAREN A's Insider Trading at Repligen Corporation (RGEN)

Buys

0 · $0.00

Sells

1 · $44.3K

Total Shares Bought

Total Shares Sold

275

RGEN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 17, 2025↗	Sell	275	$161.00	$44.3K	0

DAWES KAREN A's Insider Trading at Barinthus Biotherapeutics plc (BRNS)

Buys

1 · $28.9K

Sells

0 · $0.00

Total Shares Bought

1,700

Total Shares Sold

BRNS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 4, 2021↗	Buy	1,700	$17.00	$28.9K	0

Related Insiders

Olivier Loeillot

Chief Executive Officer

RGENSell · Nov 25, 2025

James Bylund

Chief Operating Officer

RGENSell · Nov 18, 2025

Anthony Hunt

Director

RGENSell · Nov 13, 2025

Jason K Garland

CFO

RGENSell · Sep 25, 2025

Martin D Madaus

Director

RGENBuy · Aug 8, 2025

Margaret Pax

Director

RGENBuy · Mar 17, 2025

Explore More Insider Trading Data

RGEN Insider Trading Activity

View all insider trades at Repligen Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity